Canada · Delayed Price · Currency is CAD Restart Life Sciences Statistics
Total Valuation
CSE:HEAL has a market cap or net worth of CAD 5.50 million. The enterprise value is 4.66 million.
| Market Cap | 5.50M |
| Enterprise Value | 4.66M |
Important Dates
The next estimated earnings date is Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:HEAL has 61.08 million shares outstanding. The number of shares has increased by 126.34% in one year.
| Current Share Class | 61.08M |
| Shares Outstanding | 61.08M |
| Shares Change (YoY) | +126.34% |
| Shares Change (QoQ) | +43.85% |
| Owned by Insiders (%) | 13.75% |
| Owned by Institutions (%) | 0.94% |
| Float | 52.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.85 |
| PB Ratio | 3.56 |
| P/TBV Ratio | 6.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 34.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.01 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,748.61 |
Financial Efficiency
Return on equity (ROE) is -99.24% and return on invested capital (ROIC) is -54.55%.
| Return on Equity (ROE) | -99.24% |
| Return on Assets (ROA) | -43.74% |
| Return on Invested Capital (ROIC) | -54.55% |
| Return on Capital Employed (ROCE) | -60.62% |
| Weighted Average Cost of Capital (WACC) | -0.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.00% in the last 52 weeks. The beta is -0.81, so CSE:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | -0.81 |
| 52-Week Price Change | +50.00% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 44.56 |
| Average Volume (20 Days) | 96,602 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:HEAL had revenue of CAD 134,553 and -897,928 in losses. Loss per share was -0.03.
| Revenue | 134,553 |
| Gross Profit | 61,937 |
| Operating Income | -944,247 |
| Pretax Income | -897,928 |
| Net Income | -897,928 |
| EBITDA | -941,516 |
| EBIT | -944,247 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 1.19 million in cash and 354,094 in debt, with a net cash position of 835,115 or 0.01 per share.
| Cash & Cash Equivalents | 1.19M |
| Total Debt | 354,094 |
| Net Cash | 835,115 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 1.54M |
| Book Value Per Share | 0.03 |
| Working Capital | 730,838 |
Cash Flow
| Operating Cash Flow | -556,037 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2,731 |
| Net Borrowing | 244,966 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 46.03% |
| Operating Margin | -701.77% |
| Pretax Margin | -667.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:HEAL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -126.34% |
| Shareholder Yield | -126.34% |
| Earnings Yield | -16.33% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 24, 2025. It was a reverse split with a ratio of 0.5.
| Last Split Date | Jan 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
CSE:HEAL has an Altman Z-Score of -34.79 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -34.79 |
| Piotroski F-Score | 1 |